Table 1

Characteristics and MBL genotypes of 72 patients with ASCT
AA Patients (%) n = 53 AO/OO Patients (%) n = 19 P-value*
Gender
  Male 30 (56.6) 12 (63.2) 0.62
  Female 23 (43.4) 7 (36.8)
Mean age (SD), years 51.6 (13.9) 50.2 (14.8) 0.70
Underlying disease 0.78
  MM 14 (26.4) 6 (31.6)
  HD 8 (15.1) 5 (26.3)
  NHL 22 (41.5) 7 (36.8)
  AMN 7 (13.2) 1 (5.3)
  PL 1 (1.9) 0
  Amyloidosis 1 (1.9) 0
Active disease** 0.22
  YES 11 (20.8) 7 (36.8)
  NO 42 (79.2) 12 (63.2)

*Two-tailed Chi-squared test/Fisher exact test for categorical variables or two-tailed t-test for continuous variables.

**Active pre-transplant hematologic disease.

MM: multiple myeloma, HD: Hodgkin disease, NHL: non Hodgkin lymphoma, AMN: acute myeloid neoplasia, PL: prolymphocytic leukemia, ME: multiple sclerosis.

AA genotype: patients homozygous for wild-type structural allele (A).

AO/OO genotype: patients heterozygous or homozygous for the B, C or D alleles.

Moreto et al.

Moreto et al. BMC Immunology 2014 15:17   doi:10.1186/1471-2172-15-17

Open Data